News

Analyzing Amazon.com: Stronghold and Competitors in Retail

Analyzing Amazon.com: Stronghold and Competitors in Retail

Assessing Amazon.com in the Retail Landscape

In an ever-evolving and competitive business landscape, investors are keen to examine companies thoroughly, especially industry giants like Amazon.com Inc (NASDAQ: AMZN). In this article, we analyze Amazon's position against its primary competitors in the retail sector. Through the evaluation of critical financial metrics, market performance, and projected growth, we aim to provide valuable insights into Amazon's standing within the industry.

About Amazon.com

Amazon stands as a leading retailer on the web, functioning not just as a marketplace for its products but also allowing third-party sellers to reach customers. A significant portion of Amazon's revenue—approximately 75%—is derived from retail operations. The company also boasts a robust cloud computing segment, Amazon Web Services, contributing around 15% of its total earnings, along with 5% to 10% from advertising services. Geographically, international operations represent about 25% to 30% of Amazon's non-AWS sales, with significant contributions from countries like Germany, the UK, and Japan.

Financial Metrics Comparison

Examining the financial metrics of Amazon against its peers can reveal much about its performance. The following table summarizes some essential financial ratios and figures:

  • The Price to Earnings (P/E) ratio for Amazon is 41.66, above the industry average by a margin of 1.71x, indicating a premium valuation in the eyes of investors.
  • Amazon's Price to Book (P/B) ratio stands at 8.54, which is 1.37x greater than the industry average, suggesting potential overvaluation regarding its book value.
  • With a Price to Sales (P/S) ratio of 3.87, this figure is 2.16x higher than the industry average, indicating potential overvaluation in sales compared to its competitors.
  • The Return on Equity (ROE) of 6.19% falls 0.94% below the industry average, hinting at inefficiencies in utilizing equity for profitability.
  • In contrast, Amazon achieves an impressive EBITDA of $32.08 billion, surpassing the industry average by a factor of 4.91x, signaling robust cash flow and profitability.
  • The company’s gross profit of $31.0 billion exceeds the typical figure in the industry by 2.29x, reflecting high efficiency in core operations.
  • Moreover, Amazon's revenue growth rate of 11.04% outpaces the industry average of 7.83%, suggesting that it continues to perform strongly in the market.

Debt-to-Equity Insights

Understanding a company's debt levels is essential for assessing its financial health. Amazon's debt-to-equity (D/E) ratio is 0.52, which is lower compared to many of its peers. This indicates a conservative approach towards leveraging and a healthier balance between debt and equity. Investors often view this positively as it suggests less dependency on borrowed capital.

Key Insights from the Analysis

A review of Amazon's financial metrics reveals that its P/E, P/B, and P/S ratios are comparatively high, implying that the market may consider the stock overvalued. Nonetheless, despite a lower ROE, the substantial EBITDA, gross profit, and revenue growth indicate well-managed operations and solid market performance compared to its peers in the retail sector.

Frequently Asked Questions

What is the current standing of Amazon.com in the retail industry?

Amazon holds a significant position as a leading online retailer, outperforming competitors in numerous financial metrics such as EBITDA and revenue growth.

How does Amazon's P/E ratio compare to its industry?

Amazon's P/E ratio of 41.66 is higher than the industry average, suggesting that it is priced at a premium level by market participants.

What insights does the debt-to-equity ratio provide?

The debt-to-equity ratio of 0.52 indicates that Amazon maintains a conservative leverage strategy, generally viewed as favorable among investors.

What are Amazon's growth prospects moving forward?

Amazon's impressive revenue growth rate of 11.04% surpasses the industry average, suggesting that its growth trajectory remains strong.

Is Amazon considered overvalued based on its financial ratios?

Many metrics such as P/E, P/B, and P/S ratios point towards a potential overvaluation relative to its peers, yet its solid operational performance provides a counterbalance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading